Stonepine Capital Management as of Sept. 30, 2022
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 19 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 19.4 | $43M | 6.2M | 6.92 | |
| Quidel Corp (QDEL) | 16.1 | $36M | 502k | 71.48 | |
| Cti Biopharma | 14.8 | $33M | 5.7M | 5.82 | |
| Xeris Pharmaceuticals (XERS) | 9.1 | $20M | 13M | 1.56 | |
| Apollo Endosurgery | 7.0 | $16M | 2.8M | 5.51 | |
| Adma Biologics (ADMA) | 5.5 | $12M | 5.0M | 2.43 | |
| Urogen Pharma (URGN) | 4.2 | $9.4M | 1.1M | 8.32 | |
| Amarin Corp Plc - Spons Adr New (AMRN) | 4.2 | $9.3M | 8.5M | 1.09 | |
| Ligand Pharmaceuticals Com New (LGND) | 3.9 | $8.6M | 100k | 86.11 | |
| Rezolute Com New (RZLT) | 3.7 | $8.1M | 3.0M | 2.74 | |
| Optinose (OPTN) | 3.3 | $7.3M | 2.0M | 3.66 | |
| Affimed Therapeutics B V | 1.8 | $4.1M | 2.0M | 2.06 | |
| Exagen (XGN) | 1.5 | $3.4M | 1.3M | 2.71 | |
| Conformis | 1.5 | $3.3M | 17M | 0.19 | |
| Ovid Therapeutics (OVID) | 1.3 | $2.8M | 1.5M | 1.84 | |
| Atyr Pharma Com New (ATYR) | 0.8 | $1.8M | 601k | 3.00 | |
| Opiant Pharmaceuticals | 0.7 | $1.6M | 152k | 10.75 | |
| Evolus (EOLS) | 0.7 | $1.6M | 200k | 8.05 | |
| Xoma Corp Com New (XOMA) | 0.5 | $1.2M | 65k | 17.90 |
